Quest Diagnostics Incorporated
DGX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9,872 | $9,252 | $9,883 | $10,788 |
| % Growth | 6.7% | -6.4% | -8.4% | – |
| Cost of Goods Sold | $6,628 | $6,199 | $6,450 | $6,579 |
| Gross Profit | $3,244 | $3,069 | $3,433 | $4,209 |
| % Margin | 32.9% | 33.2% | 34.7% | 39% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,770 | $1,615 | $1,874 | $1,727 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $128 | $192 | $131 | $101 |
| Operating Expenses | $1,898 | $1,807 | $2,005 | $1,828 |
| Operating Income | $1,346 | $1,262 | $1,428 | $2,381 |
| % Margin | 13.6% | 13.6% | 14.4% | 22.1% |
| Other Income/Exp. Net | -$152 | -$106 | -$149 | $296 |
| Pre-Tax Income | $1,194 | $1,156 | $1,279 | $2,677 |
| Tax Expense | $273 | $248 | $264 | $597 |
| Net Income | $871 | $854 | $946 | $1,995 |
| % Margin | 8.8% | 9.2% | 9.6% | 18.5% |
| EPS | 7.8 | 7.59 | 8.12 | 15.9 |
| % Growth | 2.8% | -6.5% | -48.9% | – |
| EPS Diluted | 7.69 | 7.52 | 7.98 | 15.53 |
| Weighted Avg Shares Out | 111 | 112 | 116 | 125 |
| Weighted Avg Shares Out Dil | 113 | 113 | 118 | 128 |
| Supplemental Information | – | – | – | – |
| Interest Income | $25 | $11 | $10 | $1 |
| Interest Expense | $226 | $163 | $148 | $152 |
| Depreciation & Amortization | $493 | $439 | $437 | $408 |
| EBITDA | $1,894 | $1,732 | $1,820 | $3,159 |
| % Margin | 19.2% | 18.7% | 18.4% | 29.3% |